May 16 |
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
|
May 16 |
Avenue Therapeutics GAAP EPS of -$15.40 misses by $6.40
|
May 15 |
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
|
May 6 |
Avenue Therapeutics files to sell 1.42M shares
|
Apr 29 |
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Apr 26 |
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Apr 24 |
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Apr 24 |
Dow Dips Over 100 Points; Ribbon Communications Shares Spike Higher
|
Apr 24 |
Avenue Therapeutics drops 9% on 1-for-75 reverse split
|
Apr 24 |
Avenue Therapeutics Announces Reverse Stock Split
|